争议事件
以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。
返回词条共 1 条
2022
韩国监管机构对三家Celltrion公司处以罚款
罚款或处罚
韩国金融服务委员会因违反会计规则，对Celltrion、Celltrion Healthcare和Celltrion Pharm合计处以130亿韩元罚款。监管机构认定违规行为是无意的。
来源摘录
On Friday, the FSC concluded that the three firms had violated accounting rules but it was "unintentional," an outcome that barely saved them from the possibility of stock trading suspension.
South Korea's financial regulator said Wednesday that it has fined three companies of pharmaceutical giant Celltrion a combined 13 billion won (US$10.5 million) for violating accounting rules.